Company news
Jiangsu Recbio Technology Co., Ltd. news in 2026
Jiangsu Recbio Technology Co., Ltd.'s news releases, calls and decks from 2026, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 1, 2026
Voluntary announcement receipt of phase III clinical trial summary report for novel adjuvanted recombinant shingles vaccine REC610
October 29, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 2, 2026
2026 Interim Report
September 23, 2026